ClinicalTrials.govpublic full text
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
sickle cell disease, sickle cell anemia, pharmacokinetics, pharmacodynamics, pociredir, open label, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831989
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.